New immunotherapy combo takes on advanced colorectal cancer
Disease control
Recruiting now
This trial tests a new immunotherapy called STC-1010 combined with standard chemotherapy and immune boosters in people with advanced colorectal cancer that cannot be removed by surgery. The study has two parts: first, finding the safest dose in about 21-33 participants, then test…
Phase: PHASE1, PHASE2 • Sponsor: Brenus Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC